Figure 1.
Flow diagram demonstrating the disposition and lenalidomide dose reductions of 353 patients included in the study. Len+Dex, lenalidomide plus dexamethasone. *Patients still receiving lenalidomide at 12 months.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.